In the aftermath of the COVID-19 pandemic, preventive healthcare has emerged as a crucial line of defence, underscoring the pivotal role of the nutraceuticals sector as a robust economic partner for the people. The resilience demonstrated by the nutraceuticals industry during the pandemic's peaks has not only weathered the storm but is witnessing a continued surge in purchases even as the severity of the global health crisis diminishes.

According to available data, as the global nutraceuticals market expands to a staggering USD 117 billion, the Indian nutraceutical industry stands poised to play a pivotal role in combating health issues in the country, particularly amid the persistent challenges posed by the ongoing pandemic. This sector's potential contribution to India's Gross Domestic Product (GDP) is undeniably significant.

A notable trend in this surge is the heightened consumption of essential nutrients and micronutrients, including vitamins A, D, C, folate, selenium, and zinc among others. This surge in consumption is a direct response to the quest for enhanced immunity and overall health in the face of the prevailing health uncertainties.

A recent study on nutrition and nutritional supplements revealed several substances that can be smoothly integrated into everyday meals to potentially increase immunity and provide protection against the coronavirus.

From polyphenols to leguminous seeds containing plant protease inhibitors and proteins like whey protein, the possibilities for fortifying one's daily diet seem promising and aligned with the evolving needs of health-conscious individuals.

To delve deeper into the dynamics of the nutraceuticals sector and its role in shaping the health landscape of India, Drug Today Medical Times interacted with Mr. Suresh Garg, Founder and CMD, of Zeon Lifesciences, an industry expert and thought leader in the realm of nutraceuticals. In this insightful conversation, Mr. Garg explores the current state, future prospects, and the transformative impact of nutraceuticals on preventive healthcare.

Mr. Garg says that nutraceutical companies are adopting eco-friendly practices, aligning with FSSAI guidelines, to create health-targeted products. Blockchain technology improves supply chain transparency, while strict quality control processes ensure product safety. Fairtrade and sustainable sourcing practices are maintained, and ethical lab practices and cGLP standards are followed. The industry's commitment to fair trade and sustainability is reflected in collaboration, compliance, and transparency. The revised Schedule M norms by the Union Health Ministry will further enhance the industry's manufacturing standards.

Here are the excerpts.

DTMT: How do nutraceutical companies integrate innovative eco-friendly practices into their ingredient sourcing and processing?

Mr. Suresh Garg (SG)          Nutraceutical companies seamlessly integrate innovative eco-friendly practices into their ingredient sourcing and processing through a collaborative effort involving R&D teams and cross-functional departments. This process adheres to specific methodologies outlined in SOPs, ensuring the integration of diverse sources and processes. By prioritising the utilisation of biodegradable and recyclable materials compatible with our ecosystem, we align ingredient sourcing with FSSAI guidelines. This alignment facilitates the development of scientifically formulated products targeting various health needs, including medical nutrition, skincare, hair and nail care, immunity, and general wellness.

DTMT: In what ways are sustainable practices shaping the future landscape of nutraceutical production?

SG:       Sustainable practices are fundamentally reshaping the future landscape of nutraceutical production. As the industry experiences rapid growth, there's a notable shift towards integrating technologically advanced systems to reduce direct human involvement across different process stages. Despite strides made, the complete adoption of sustainability remains a journey. At Zeon, we are steadfast in our commitment to embedding sustainable practices into our manufacturing. We've embraced an operational excellence model aimed at achieving zero waste, zero defects, and zero accidents, aligning with our vision for a greener, more efficient future.

DTMT: How does blockchain technology enhance transparency and traceability in nutraceutical supply chains? 

SG:       Blockchain technology significantly enhances transparency and traceability in nutraceutical supply chains by serving multiple purposes at individual and mass levels. Its primary objectives include ensuring accuracy, traceability, scalability, and transparency. With features like easy access control and robust security measures, blockchain maintains consistent performance. At Zeon, we integrate these attributes into our facility and supply chain management practices, aligning with our commitment to transparency and reliability.

DTMT: What measures can be taken to ensure transparency in the nutraceutical industry, specifically from farm to bottle?

SG:       Ensuring transparency in the nutraceutical industry, particularly from farm to off-shelf, requires a systematic approach based on predetermined SOPs to uphold quality standards. There should be strict guidelines to comply with quality standards and be monitored through audits for implementation and certification. A robust supply chain backed by traceability will play a crucial role in bridging the gap between the industry and the consumer. On the other hand, industry-wide collaboration on standardised reporting practices and ethical sourcing guidelines fosters a culture of openness. Ultimately, a blend of technological innovation, stringent audits, and collaborative efforts across the supply chain upholds transparency in the nutraceutical sector.

DTMT: Could you elaborate on the stringent quality control processes that ensure the safety of nutraceutical products behind the scenes?

SG:       Stringent quality control processes are essential to ensuring the safety of nutraceutical products behind the scenes, encompassing three critical levels of scrutiny. The first level involves material purchase, where we assess everything from vendor assessment and qualification to ingredient approval through a NABL-accredited lab. At the second level, we ensure quality during in-process (IQC) manufacturing. Finally, at the third level, we ensure it through the final testing of the finished product. Additionally, the role of storage and the supply chain is paramount in safeguarding the product until it reaches the consumer.

DTMT: What safety measures does the nutraceutical industry employ to build consumer trust?

SG:       For any industry, safety is the utmost measure to be taken care of, and it is even more critical in the case of the food and nutritional industry. At an industry level, this should be achieved by implementing strict compliance and SOPs designed to formulate a finished product from its origin to off-the-shelf. Further, at the consumer level, publicly accessible databases detailing sourcing, production processes, and testing results enhance consumer trust. Clear labelling with comprehensive ingredient information further promotes transparency.

DTMT: How does a nutraceutical company implement fair trade and sustainable sourcing practices for its ingredients?

SG:       Implementing fair trade and sustainable sourcing practices for ingredients is crucial for a nutraceutical company's integrity and responsibility. This process begins with vendor qualification and approval, ensuring adherence to harmonised international standard operating procedures. Techno-commercial considerations are integrated into sourcing practices, prioritising fairness and sustainability. By following these norms, transparency is maintained throughout the supply chain, ensuring that ingredients meet ethical and environmental standards.

DTMT: What initiatives are taken to ensure ethical lab practices throughout the nutraceutical supply chain?

SG:       Ensuring ethical lab practices throughout the nutraceutical supply chain involves adherence to cGLP standards defined by international harmonisation or various governing bodies, whether regional or international. These standards ensure the quality, safety, and efficacy of products throughout their shelf life. At Zeon, we are committed to following all SOPs to deliver scientifically developed formulations, maintaining integrity and transparency at every stage of production.

DTMT: Can you discuss the commitment of the nutraceutical industry to ethical sourcing and labour practices as part of responsible business practices?

SG:       In recent times, there has been increased awareness among industries and individuals regarding government regulations aimed at preventing malpractices and ensuring ethical manpower sourcing, including compliance with child labour laws and labour regulations. At Zeon, we prioritise adherence to established guidelines and human resource management policies, ensuring ethical sourcing and fair labour practices throughout our operations.

DTMT: In what ways does the industry contribute to fair trade and sustainability in its overall operations?

SG:       The industry's commitment to fair trade and sustainability is integral to its overall operations. While financial sustenance is crucial, the industry also prioritises sustainable methods to develop products aligned with consumer demand. Delivering quality products is essential for feasibility and sustainability, requiring collaboration with scientific innovations, compliance, and transparent practices. This involves sharing guidelines and information throughout the supply chain to ensure transparency and meet the needs of all stakeholders.

DTMT: How, in your opinion, are the revised Schedule M norms unveiled by the Union Health Ministry recently going to affect the nutraceutical industry?

SG:      The recently unveiled revised Schedule M norms by the Union Health Ministry are poised to have a significant impact on the nutraceutical industry. These norms, which define practices involving standard operating procedures (SOPs) as per the cGMP, adhere to uniform guidelines adopted by the industry. Given that these practices are internationally harmonised manufacturing standards, they are expected to positively influence the nutraceutical industry as well. At Zeon, we advocate for the adoption of such norms as part of our commitment to delivering "a promise of good health."